This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Sheri Ambriz
Vice President of Oligonucleotide Business Development at CPC Scientific
Speaker

Profile

Sheri Ambriz serves as the Vice President of Oligonucleotide Business Development at CPC Scientific. With over 25 years of experience spanning the life sciences, biotechnology, pharmaceutical, and CDMO sectors, she has held a range of leadership roles in process development, research and development, manufacturing, and business development. Sheri holds a B.S. in Biology from the University of California, Santa Cruz, and an MBA from San Francisco State University. She brings extensive expertise in oligonucleotide development and manufacturing, along with a proven track record of strategic leadership and industry insight.

Agenda Sessions

  • Green Approaches to Peptide and Peptide-Oligonucleotide Manufacturing

    7:45am